
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China. …